arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CareDx, Inc.

CDNA
$46.70 ▲ +1.92 (+4.29%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
56 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
31
Health
Poor
Bearish
auto_awesome

Analytical Summary

CareDx, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.4B
Dividend Yield
Revenue Growth 52.2%
Op. Margin 85.8%
ROIC 25.7%
FCF / Share $0.56
Trailing P/E 21.7x
Price / Book 5.7x
FCF Yield 1.2%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

56-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$131.95M
↑ +52.2%
Net Income Profit after all expenses
$2.81M
— 0.0%
Operating Margin Operating profit as % of sales
85.8%
↑ +8330.5% 17th
FCF / Share Free cash flow per share
$0.56
↑ +5458.1%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
34
Returns
37
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 56 quarters